Dysregulation of selected lncRNAs and Hippo/EMT-associated genes in hepatocellular carcinoma patients

Authors

  • Ana Maria Ciurdorean 3rd Dept. of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Paul Chiroi Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Liviuta Budisan Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Ekaterina Isachesku Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Alexandra Trif Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Stefan Strilciuc Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Daniel Gabriel Cosma Faculty of Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Ioana Rusu Department of Pathology, Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Andra Ciocan 3rd Dept. of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Surgery, Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania
  • Razvan Ciocan Department of Surgery-Practical Abilities, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
  • Ioana Berindan-Neagoe Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Doctoral School, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Romanian Academy of Medical Sciences, Biomedical Sciences, Bucharest, Romania https://orcid.org/0000-0001-5828-1325 (unauthenticated)
  • Nadim Al Hajjar 3rd Dept. of Surgery, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Surgery, Octavian Fodor Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania

DOI:

https://doi.org/10.15386/mpr-3032

Keywords:

hepatocellular carcinoma, RNA, long noncoding, gene expression profiling, epithelial-mesenchymal transition, Hippo signaling pathway, real-time polymerase chain reaction

Abstract

Background and aim: Liver cancer remains the sixth most common malignancy and the third leading cause of cancer-related death worldwide, with hepatocellular carcinoma accounting for most cases. Long non-coding RNAs regulate hepatocarcinogenesis by modulating proliferation, epithelial–mesenchymal transition, and invasion. This study aimed to characterize the expression of three such transcripts (MALAT1, NEAT1, NKILA) and two protein-coding genes of the Hippo/EMT axis (YAP1, SNAI1) in a single-center Romanian cohort of hepatocellular carcinoma patients and to interpret the resulting pattern in relation to the existing literature.

Methods: Tumoral and non-tumoral liver tissue samples were obtained from patients with non-metastatic hepatocellular carcinoma undergoing surgical resection. Total RNA was extracted using TRIzol, reverse-transcribed, and quantified by SYBR Green–based qRT-PCR on a QuantStudio 7 Flex platform. Relative expression was calculated by the ΔΔCt method, normalized to B2M and 18S rRNA, and compared between the two groups using GraphPad Prism; p < 0.05 was considered significant.

Results: 39 tumoral and 39 non-tumoral tissue samples were analyzed. MALAT1 (p = 0.0008), YAP1 (p = 0.0016), and SNAI1 (p = 0.0365) were significantly overexpressed in tumoral tissue, whereas NEAT1 was significantly reduced (p = 0.0320). NKILA showed no significant difference between groups (p = 0.3592). Effect sizes were graded, with the strongest separation for MALAT1 and YAP1 and more modest differences for SNAI1 and NEAT1.

Conclusion: MALAT1, YAP1, and SNAI1 overexpression in hepatocellular carcinoma was confirmed in a single-center cohort from Romania, including predominantly early-stage subjects. The reduction of NEAT1 diverges from most prior reports and may reflect isoform-specific detection or the molecular abnormality of the cirrhotic tissue comparator. Future work should incorporate isoform-specific assays, etiology-stratified cohorts, and outcome correlation.

 

Downloads

Published

2026-09-21

Issue

Section

Original Research

How to Cite

1.
Dysregulation of selected lncRNAs and Hippo/EMT-associated genes in hepatocellular carcinoma patients. Med Pharm Rep [Internet]. 2026 Sep. 21 [cited 2026 Nov. 19];99(4):311-9. Available from: https://medpharmareports.com/index.php/mpr/article/view/3032